Paper Details

  1. Home
  2. Paper Details

[Famciclovir treatment of patients with chronic hepatitis B virus infection].

Author: JiDong, LiLi, ShaoQing, ZhangJian

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Famciclovir was effective and safe for the treatment of chronic hepatitis B virus (HBV) infection, achieving a negative serum HBV DNA in 40.62% of patients compared to 37.93% and 67.90% for interferon alpha and lamivudine, respectively.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To evaluate the effects of famciclovir treatment of patients with chronic hepatitis B virus (HBV) infection. METHODS: Eighty-nine patients with chronic HBV infection were randomly divided into three groups. Thirty-two patients were treated with famciclovir, 29 patients and 28 patients wi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/12665916

データ提供：米国国立医学図書館（NLM）

Famciclovir for the Treatment of Chronic Hepatitis B Virus Infection

Chronic hepatitis B virus (HBV) infection is a serious health issue. This research explored the effectiveness of [famciclovir] as a treatment option for patients with chronic HBV infection. They conducted a randomized controlled trial comparing famciclovir to interferon alpha and lamivudine.

Famciclovir Shows Promise as a Treatment Option

The study found that [famciclovir was effective] in reducing HBV DNA levels and HBeAg levels in patients with chronic HBV infection. It’s like finding a new oasis in the desert, offering a potential path to recovery from chronic HBV infection.

Managing Chronic Hepatitis B Infection

This study provides valuable information for clinicians treating chronic HBV infection. While more research is needed, the findings suggest that famciclovir could be a viable treatment option. It’s important to work with a healthcare professional to determine the best treatment plan based on individual needs and preferences.

Dr. Camel's Conclusion

This research offers a promising avenue for treating chronic HBV infection. The findings suggest that famciclovir could be a valuable tool in the fight against this debilitating condition.

Date :
  1. Date Completed 2003-11-21
  2. Date Revised 2018-11-30
Further Info :

Pubmed ID

12665916

DOI: Digital Object Identifier

12665916

SNS
PICO Info
in preparation
Languages

Chinese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.